Manufacturer Nexus Pharmaceuticals has issued a voluntary recall of two lots of its benztropine mesylate injection. The recall affects the 2 mg / 2 ml, single dose 2 ml vials, and is due to the possibility of visible particulate matter in the vials.
The recall is precautionary; there haven’t been any reported reactions, complaints, or adverse effects at this time.
Nexus is arranging for the return of all affected products, and you can call their customer line at 888-806-4606 with any questions on how to return any unused vials.
The affected lots of benztropine mesylate (030712 and 112911) have the NDC number 14789-300-02, and expire in 3/2014 and 11/2013.